Vaccine maker recounts 'breakfast table' pivot to COVID work
BERLIN (AP) — The doctor who led development of the first COVID-19 vaccine authorized in the United States, Britain and elsewhere said her company's decision to shift from cancer research to battling the coronavirus happened over breakfast as the possibility of a pandemic was starting to seem likely.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
